Go Pro

Amrize (NYSE:AMRZ) Insider Mario Gross Buys 3,568 Shares of Stock

Amrize logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Insider buying: Mario Gross purchased 3,568 Amrize shares at an average $46.60 each, investing $166,268.80 and increasing his holdings by 10.22% to 38,485 shares.
  • Recent performance: Amrize shares traded near $46.65, close to their 12-month low of $46.03 and below their 50-day and 200-day moving averages. The company recently reported quarterly EPS of $0.88, missing the $0.92 analyst consensus, on $3.50 billion in revenue.
  • Investor outlook: Amrize declared a $0.11-per-share dividend payable August 26, while analysts maintain a “Moderate Buy” consensus rating with a $60.57 average price target.
  • Five stocks to consider instead of Amrize.

Amrize Ltd (NYSE:AMRZ - Get Free Report) insider Mario Gross bought 3,568 shares of the firm's stock in a transaction on Tuesday, August 11th. The stock was bought at an average price of $46.60 per share, with a total value of $166,268.80. Following the completion of the purchase, the insider owned 38,485 shares of the company's stock, valued at $1,793,401. This trade represents a 10.22% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Mario Gross also recently made the following trade(s):

  • On Wednesday, May 20th, Mario Gross purchased 1,200 shares of Amrize stock. The shares were bought at an average price of $48.63 per share, for a total transaction of $58,356.00.
  • On Tuesday, May 19th, Mario Gross purchased 2,800 shares of Amrize stock. The shares were bought at an average price of $49.17 per share, for a total transaction of $137,676.00.

Amrize Stock Performance

Shares of NYSE AMRZ traded up $0.28 during mid-day trading on Thursday, hitting $46.65. The company had a trading volume of 1,261,074 shares, compared to its average volume of 3,206,131. Amrize Ltd has a 12 month low of $46.03 and a 12 month high of $65.94. The stock has a market cap of $25.80 billion, a price-to-earnings ratio of 21.50, a PEG ratio of 1.02 and a beta of 0.11. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The firm's 50 day simple moving average is $51.50 and its two-hundred day simple moving average is $54.58.

Amrize (NYSE:AMRZ - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). Amrize had a return on equity of 10.17% and a net margin of 9.89%.The company had revenue of $3.50 billion for the quarter. As a group, equities research analysts forecast that Amrize Ltd will post 2.72 earnings per share for the current year.

Amrize Dividend Announcement

The company also recently declared a dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 19th will be given a dividend of $0.11 per share. The ex-dividend date is Tuesday, August 18th. Amrize's dividend payout ratio is currently 20.28%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on AMRZ shares. Sanford C. Bernstein reiterated an "outperform" rating on shares of Amrize in a research report on Monday, June 22nd. Citigroup dropped their price target on shares of Amrize from $66.00 to $58.00 and set a "buy" rating on the stock in a research note on Tuesday. Vertical Research raised Amrize from a "hold" rating to a "buy" rating and set a $70.00 price target on the stock in a report on Friday, May 1st. Oppenheimer reduced their price objective on Amrize from $68.00 to $65.00 and set an "outperform" rating for the company in a research report on Tuesday, July 21st. Finally, Wells Fargo & Company decreased their price objective on Amrize from $65.00 to $58.00 and set an "overweight" rating for the company in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $60.57.

Check Out Our Latest Report on Amrize

Hedge Funds Weigh In On Amrize

Large investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in Amrize by 5.6% during the fourth quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company's stock worth $1,722,500,000 after purchasing an additional 1,676,843 shares in the last quarter. Norges Bank acquired a new position in shares of Amrize during the 4th quarter valued at $929,333,000. Wellington Management Group LLP increased its position in shares of Amrize by 48.8% during the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock valued at $561,018,000 after purchasing an additional 3,809,133 shares during the period. Harris Associates L P bought a new stake in shares of Amrize in the 4th quarter worth $615,406,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Amrize by 1.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,674,921 shares of the company's stock worth $532,076,000 after buying an additional 156,903 shares in the last quarter.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Insider Buying and Selling by Quarter for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines